INTERFERON - PHARMACOKINETICS AND TOXICITY

被引：32

作者：

SCOTT, GM

机构：

来源：

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES | 1982年 / 299卷 / 1094期

关键词：

D O I：

10.1098/rstb.1982.0109

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：91 / 107

页数：17

共 106 条

[51]

HOROSZEWICZ JS, 1978, CANCER TREAT REP, V62, P203

[52]

IKIC D, 1981, LANCET, V1, P1022

[53]

IKIC D, 1981, LANCET, V1, P1027

[54]

IKIC D, 1975, P S CLIN USE INTERFE, P229

[55]

IKIC D, 1975, P S CLIN USE INTERFE, P203

[56] SIDE-EFFECTS OF LONG-TERM TREATMENT WITH HUMAN-LEUKOCYTE INTERFERON [J].

INGIMARSSON, S ;

CANTELL, K ;

STRANDER, H .

JOURNAL OF INFECTIOUS DISEASES, 1979, 140 (04) :560-563

[57] INTRATHECAL INTERFERON REDUCES EXACERBATIONS OF MULTIPLE-SCLEROSIS [J].

JACOBS, L ;

OMALLEY, J ;

FREEMAN, A ;

EKES, R .

SCIENCE, 1981, 214 (4524) :1026-1028

[58]

JOHNSON PE, 1976, J CLIN MICROBIOL, V4, P106

[59] CLINICAL-TRIALS OF TOPICAL INTERFERON THERAPY OF ULCERATIVE VIRAL KERATITIS [J].

JONES, BR ;

COSTER, DJ ;

FALCON, MG ;

CANTELL, K .

JOURNAL OF INFECTIOUS DISEASES, 1976, 133 :A169-A172

[60] ADMINISTRATION OF HUMAN LEUKOCYTE INTERFERON IN HERPES-ZOSTER .1. SAFETY, CIRCULATING ANTIVIRAL ACTIVITY, AND HOST RESPONSES TO INFECTION [J].

JORDAN, GW ;

FRIED, RP ;

MERIGAN, TC .

JOURNAL OF INFECTIOUS DISEASES, 1974, 130 (01) :56-62

← 1 2 3 4 5 6 7 8 9 10 →